person · Reporting owner
Weinstein David Hershel
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lunai Bioworks Inc.RENB · Entity 7981 | Director · Chief Executive Officer | October 14, 2024 | October 29, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lunai Bioworks Inc.
Report date October 14, 2024 · Filed October 29, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 250,000 |
Reported balance
After 2024-10-14 transaction · row 1
1 source rowRow 1 · 2024-10-14 · Grant · Acquired 250,000 · Balance 250,000 |
| Option to purchase shares of common stockSEC Table II · derivative / convertible security · Conversion / exercise price $0.55 · Expires 2034-10-14 | Direct | 1,600,000 |
Reported balance
After 2024-10-14 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-10-14 · Grant · Acquired 1,600,000 · Balance 1,600,000 F1: The option vests in eight equal quarterly installments beginning on January 1, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in eight equal quarterly installments beginning on January 1, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 14, 2024 Filed Oct 29, 2024 14:36 UTC | Lunai Bioworks Inc. RENB · Entity 7981 | GrantOption to purchase shares of common stock · Derivative | 1,600,000 | $0.00 Strike: $0.55 | $0.00 |
DisclosureSEC source: 0001731122-24-001669 · ownership.xml · derivative · entry 2 Weinstein David Hershel · CIK 0002042640 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,600,000 Underlying: Common stock · 1,600,000 shares Expires 2034-10-14 F1 · derivative.exercise_date: The option vests in eight equal quarterly installments beginning on January 1, 2025. Read SEC document |
| October 14, 2024 Filed Oct 29, 2024 14:36 UTC | Lunai Bioworks Inc. RENB · Entity 7981 | GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001731122-24-001669 · ownership.xml · nonDerivative · entry 1 Weinstein David Hershel · CIK 0002042640 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.